Member Info for Lazarus2

So that would equate to a market cap of £340m @£5 per share Surfie.

Apply the value of success in both 1810 &1802 and you can see where investors are coming from. Failure would admittedly leave us at rock bottom. But most do not invest in a stock to see it fail. Risk/reward here is high but being de-risked every day or week that goes by with no red flags. We really are at the business end of Sareums journey in more ways than one.

Our choice, our money, our risk. I do appreciate that it isn’t for everyone including yourself. The decision as to when to sell is a tough one. Provided we all make money of some sort then it has to be a good share to be in

No problem

Funnyguy - you appear to be a sneering and negative poster - why don’t you post your own opinion which would be welcomed as opposed to mocking others.

In terms of sp why don’t you translate that to market cap and see what you come up with. Then look at asset value or potential asset value.

Our money, our choice, our risk - but thanks for your detailed analysis. Some will have found it useful I’m sure.

I didn’t say that I didn’t want a buyout at all stevbru. If it comes it comes. Please stop misrepresenting me - thanks

They could take shares equivalent in lieu of cash.

Oracle - don’t despair - Sareum is not a one trick pony as has been observed many times (apologies) 1802 will quickly join 1801 as it’s out of the same stable so to speak. The exciting aspect is that psoriasis is only the beginning. Much more to come if we stay the course and we are not bought out.

MMs will have to increase the bid just to attract more sellers - not many about at these levels

Into week 3 now and a decent start this morning. I am anticipating the sp to continue to strengthen as nothing adverse is reported and we progress to the end of Part 1 of ph1a- still a snip at these levels IMO

Very good article and nobody should be in any doubt as to what we have and where we are going with it. Read better than an RNS.

2weeks into the trial and nothing adverse reported.

Ducks! Ducks! Ducks!

Nice to know altruism is alive and kicking here in the form of Surfie wanting to help Newbies. Anyone investing based on chatboard comments needs their head examining! Plenty of good, balanced information in the public domain Surfie.

@ funnyguy - GSK hand it back to CRUK and Sareum then buy Sareum out completely and own everything rather than complex license deal with milestones and royalties. That would include 1801 and 1802 - not a forecast from me but just a positive spin on events as you requested.

Think you might be right Bigbear - The buy at 3.36 is my 200k shares and not the quantity printed. Showing as 200k in my broker account.

"Sarn't Major! Would you say the troops are revolting?"

"Certainly sir - The troops are revolting"

Looks like a buy to me - probably one of the reasons it has been taken down to fill orders at this level.

Hi Potnak - your simplistic argument is only correct when you apply supply and demand principles. You are intelligent and therefore I would presume you would understand the darker arts of both investing and trading.

Dark forces - agreed - it’s just manipulation.

Why - money

Who - mms/brokers/traders

Different tactics such as U/T’s to manipulate following day sp opening.

Cancelled large trades after hours

Fake news/negative articles that are disingenuous.

If hedge funds can reek havoc on larger stocks then anything can, and usually does, happen to smaller stocks

If a conspiracy of large Banks can manipulate LIBOR then we had all better watch out.

Spoof trades etc: it is all on the public domain if you look.

Supply and demand? It works with widgets, commodities etc: but not with share prices I’m afraid. Where there is money, corruption is not far behind in all walks of life.

Just my view

You are right Ahfam - there will be a concerted effort at some point to drive the sp down. Traders will want low risk and a low sp to maximise return. Unfortunately, as the risk lowers the sp should increase. We are at the point in Sareums development whereby the risk will now begin to decrease as we progress through Ph1a.

All good here and no news is good news.

Still very much undervalued. I wonder if there will be some chunkier buys later today as news spreads in USA/Boston about Sareum - the new kid on the block.

Nice on Krone. So both ICR and Sareum are there - no doubt 737 is well represented with both partners able to participate in any discussions

Well it is better than the last one and has a positive slant to it. The funding comment is “may be required by end calendar year 2023. So in their opinion 6 months to raise fund as suggested by Aber.

Hi Silverfoil. It is their first one for Sareum and was issued quite a while ago.

Right on cue - and back to the point of resistance that has been evident for a few months now (£1.29 according to whoever posted)